SCHEMBL6981009

SCHEMBL6981009

O=C(c1cccnc1Cl)[N+]1(CCO)CCC(CNC[C@H]2COc3ccc(Cl)cc3O2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 8/20 0.46
ADRA1A P35348 8/20 0.46
ADRA1B P35368 8/20 0.46
DRD2 P14416 2/20 0.46
DRD4 P21917 2/20 0.46
DRD3 P35462 2/20 0.46
HTR1A P08908 1/20 0.46
HTR2C P28335 1/20 0.46
CA2 P00918 2/20 0.41
TSHR P16473 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
FFAR1 O14842 2/20 0.37
CA1 P00915 1/20 0.37
POLB P06746 1/20 0.36
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL8381334 0.80 ADRA1D (0.56) ADRA1DADRA1AADRA1BDRD2DRD4
Alcohol SCHEMBL8547581 0.80 ADRA1D (0.56) ADRA1DADRA1AADRA1BDRD2DRD4
SCHEMBL6970869 0.75 ADRA1D (0.54) ADRA1DADRA1AADRA1BDRD2DRD4
SCHEMBL6977646 0.71 ADRA1D (0.58) ADRA1DADRA1AADRA1BDRD2DRD4
SCHEMBL8096185 0.70 ADRA1D (0.58) ADRA1DADRA1AADRA1BDRD2DRD4
SCHEMBL8096179 0.70 ADRA1D (0.58) ADRA1DADRA1AADRA1BDRD2DRD4
SCHEMBL6980022 0.67 ADRA1D (0.50) ADRA1DADRA1AADRA1BDRD2DRD4
SCHEMBL6985811 0.67 ADRA1D (0.50) ADRA1DADRA1AADRA1BDRD2DRD4
SCHEMBL6977805 0.67 ADRA1D (0.50) ADRA1DADRA1AADRA1BDRD2DRD4
SCHEMBL8386689 0.67 ADRA1D (0.50) ADRA1DADRA1AADRA1BDRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP disclosed